DiscoverThis Week in Addiction Medicine from ASAM
This Week in Addiction Medicine from ASAM
Claim Ownership

This Week in Addiction Medicine from ASAM

Author: American Society of Addiction Medicine

Subscribed: 72Played: 647
Share

Description






This Week in Addiction Medicine is an audio summary of the recent top stories and research articles from the field of addiction medicine. Intended to serve as an accompaniment to the ASAM Weekly newsletter or as a stand-alone resource, This Week covers recent publications in addiction medicine research.















237 Episodes
Reverse
Patient-reported changes in alcohol use following glucagon-like peptide-1 receptor agonist initiation JAMA Psychiatry Using a nationally representative survey of US adults, this study estimated the population prevalence of patient-reported reductions in alcohol use following glucagon-like peptide-1 receptor agonist (GLP-1 RA) initiation and assessed public awareness of the potential impact of GLP-1 RAs on alcohol use.  Researchers found that nearly half of individuals who used a GLP-1 RA reported they reduced their alcohol consumption; individuals with potentially unhealthy drinking were more likely to report reductions. Although large clinical trials are needed to draw conclusions about the relationship between GLP-1 RAs and alcohol use, it is notable that such a large fraction of GLP-1 users in this survey reported reductions.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM
Online sports betting legalization and behavioral health care use  JAMA Psychiatry This quasi-experimental difference-in-differences study including almost 62 million enrollee-years assessed the association between online sports betting legalization and behavioral health care use.  Researchers found that online sports betting legalization was associated with an increase in the probability of people with employer-sponsored health insurance having a prescription fill or outpatient visit related to depression or anxiety. Associations were more precise and robust for men than women, and legalization was not associated with changes in prescriptions or outpatient visits for a substance use disorder. Results suggest state legalization of online sports betting was associated with measurable increases in mental health care use and may increase strain on the behavioral health system.    Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM
Alcohol use screening, brief intervention and referral to treatment cascade of care in the USA: Variation by alcohol use and socio-demographic characteristics Addiction  Screening, brief intervention and referral to treatment (SBIRT) is an evidence-based intervention and researchers used a large data set to assess utilization of each step in the care cascade unconditional on the previous step. Overall, 16% of individuals reported past-year heavy alcohol use and 11% met criteria for alcohol used disorder (AUD). Among those reporting past-year healthcare utilization, 69% reported being screened, with those ≥50 years old and non-white individuals being less likely to be screened. Overall, 8.4% of individuals received BI, with <4% of those reporting heavy alcohol use receiving BI. Among those meeting criteria for AUD only 7% were referred to treatment, while 8% reported treatment in the last year. Women were less likely to receive BI and referral for treatment. Authors note these data highlight the need to better implement SBIRT addressing gaps and differences in access to care cascade.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM
The effect of stimulant medications on symptom and treatment outcomes in adults with comorbid attention-deficit/ hyperactivity and substance use disorder: A systematic review and meta-analysis Journal of Attention Disorders ADHD and SUDs have shared genetic vulnerability and 20% of people with a SUD have co-occurring ADHD. This systemic review and meta-analysis assessed the risks and benefits of stimulant treatment in patients with both diagnoses. Seven studies met inclusion criteria; six were randomized controlled trials. Among patients with co-occurring SUD and ADHD, comparing those prescribed stimulants to those not prescribed stimulants, there was no evidence for a difference in substance use, SUD symptoms, substance abstinence, or ADHD treatment adherence. Only 2 of 5 studies showed improvement in ADHD symptoms with stimulant treatment. One study found significantly longer SUD treatment retention in those prescribed stimulants. Although there was no clear evidence of harm associated with treatment with stimulants, they caution that significant limitations in the quality of evidence result in low confidence for all these conclusions.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM  
Projected health and economic outcomes in people who inject drugs in the United States, 2025-2034: A modeling study Open Forum Infectious Diseases This modeling study developed a microsimulation model, the Multimorbidity model to Reduce Infections Associated with Drug use (MYRIAD). Key clinical outcomes and costs were projected from 2025-2034 in the US, including new HIV and HCV cases, hospitalizations for severe injection-related infections, and deaths from drug overdose and injection-related infections. For 3.3 million people who inject drugs over 10 years, the model predicted 487,249 deaths, 29,715 new HIV infections, 218,186 new HCV infections/reinfections, and 1.7 million hospitalizations related to injection drug use, with a projected health care cost of $565 billion.    Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM
loading
Comments